发明名称 Monoclonal antibodies against antithrombin β
摘要 This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin β complexed with heparin and/or heparin-like structure (ATβH). These ATβH binding proteins can block the anti-coagulant activity of ATβ to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.
申请公布号 US9593166(B2) 申请公布日期 2017.03.14
申请号 US201414214382 申请日期 2014.03.14
申请人 BAYER HEALTHCARE LLC 发明人 Jin Ye;Murphy John E.;Hermiston Terry;Myles Timothy;Dittmer Frank;Strerath Michael;Gritzan Uwe
分类号 C07K16/18;A61K45/06;A61K39/395;C07K16/36;A61K38/48;C07K16/38 主分类号 C07K16/18
代理机构 代理人
主权项 1. A monoclonal antibody capable of binding AtβH, wherein the heavy chain of said antibody comprises: a HCDR1 comprising SEQ ID NO: 40, a HCDR2 comprising SEQ ID NO: 45, and a HCDR3 comprising SEQ ID NO: 50; and wherein the light chain of said antibody comprises: a LCDR1 comprising SEQ ID NO: 21, a LCRD2 comprising SEQ ID NO: 26, and a LCDR3 comprising SEQ ID NO: 31.
地址 Whippany NJ US